OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Orabloc 4 % / 1:100,000 in 1.8 mL Dental Cartridge [PSN] · 1.8 ML articaine hydrochloride 40 MG/ML / epinephrine 0.01 MG/ML Cartridge [Orabloc] [SBD] · Orabloc 4 % / 1:100,000 in 1.8 mL Dental Cartridge [SY]
3
20
These highlights do not include all the information needed to use ORABLOC® safely and effectively. See full prescribing information for ORABLOC®. ORABLOC® (articaine HCl and epinephrine) injection, for intraoral submucosal infiltration use Initial U.S. Approval: 2000
These highlights do not include all the information needed to use Articaine HCL and Epinephrine safely and effectively. See full prescribing information for Articaine HCL and Epinephrine. Articaine HCL and Epinephrine Injection, for intraoral submucosal infiltration use Initial U.S. Approval: 2000
These highlights do not include all the information needed to use Articaine HCL and Epinephrine safely and effectively. See full prescribing information for Articaine HCL and Epinephrine. Articaine HCL and Epinephrine Injection, for intraoral submucosal infiltration use Initial U.S. Approval: 2000
These highlights do not include all the information needed to use ORABLOC® safely and effectively. See full prescribing information for ORABLOC®. ORABLOC® (articaine HCl and epinephrine) injection, for intraoral submucosal infiltration use Initial U.S. Approval: 2000
These highlights do not include all the information needed to use ORABLOC® safely and effectively. See full prescribing information for ORABLOC®. ORABLOC® (articaine HCl and epinephrine) injection, for intraoral submucosal infiltration use Initial U.S. Approval: 2000
These highlights do not include all the information needed to use ORABLOC® safely and effectively. See full prescribing information for ORABLOC®. ORABLOC® (articaine HCl and epinephrine) injection, for intraoral submucosal infiltration use Initial U.S. Approval: 2000